Osteoporosis News and Research

Latest Osteoporosis News and Research

Study: Half of Canadians with osteoporosis have insufficient levels of vitamin D

New data presented today at the American Society for Bone and Mineral Research 2010 Annual Meeting held in Toronto, Ontario, demonstrated that approximately half of Canadians with osteoporosis have insufficient levels of vitamin D (less than 80 nmol/L), despite the fact that more than 40 per cent are prescribed at least 2800 IU of vitamin D per week.

19 Oct 2010

Study indicates vitamin D deficiency may increase lung transplant rejection

Vitamin D deficiency is associated with a significant increase in lung transplant rejection, according to research conducted at Loyola University Health System (LUHS). These data were presented Monday at The American Society for Bone and Mineral Research 2010 annual meeting in Toronto, Ontario.

19 Oct 2010

IBD patients with Vitamin D deficiency at greater risk of osteoporosis, osteopenia

Vitamin D deficiency puts patients with Inflammatory Bowel Disease (IBD) at greater risk of osteoporosis, osteopenia and an overall higher rate of abnormal bone density, according to the results of a new study unveiled today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas.

18 Oct 2010

14 global studies on osteoporosis medications FORTEO and EVISTA to be presented at ASBMR 2010

Eli Lilly and Company today announced that a total of 14 U.S. and global studies involving its osteoporosis medications, FORTEO® [teriparatide (rDNA origin) injection] and EVISTA® (raloxifene HCl tablets), will be presented at the American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting from October 15-19 in Toronto, ON, Canada.

18 Oct 2010

Women with normal bone mineral density at age 67 don't need osteoporosis screening again for 10 years

Since 2002, the U.S. Preventive Services Task Force has recommended that women ages 65 and older be routinely screened for osteoporosis and has suggested that a 2-year screening interval might be appropriate. However, what length the screening interval should be is a topic that remains controversial and undecided, with no definitive scientific evidence to provide guidance.

18 Oct 2010

Six-year data of reinforces efficacy and safety of Reclast injection in postmenopausal women with osteoporosis

Novartis announced today that new six-year data reinforce the long-term efficacy and safety profile of once-yearly Reclast (zoledronic acid) injection in postmenopausal women with osteoporosis. The study of more than 1,200 women was presented this weekend at the annual meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, ON, Canada.

18 Oct 2010

Researchers identify genes that predict early menopause

The first research from the Breakthrough Generations Study could lead to a test to predict a woman's reproductive lifespan. The findings, published today in Human Molecular Genetics, could have considerable impact on women in the UK and other western countries, where many start having children at a later age. Early menopause affects one in 20 UK women.

18 Oct 2010

$Spinal fractures remain undiagnosed and untreated$

Spinal fractures remain undiagnosed and untreated

A new report issued by the International Osteoporosis Foundation (IOF) for World Osteoporosis Day puts the spotlight on the severe impact of spinal fractures and calls on health professionals to recognize the signs of these fractures in their patients.

15 Oct 2010

Officials address several drug issues including medical risks, proper disposal of unused medicine

Federal and state officials are addressing several drug issues including the risks associated with bone-strengthening drugs, complaints about a blood-thinning drug and a new law to help people safely dispose of unused medicine.

15 Oct 2010

U.S. Bone and Joint Decade observes National Action Week

An annual global event, Bone and Joint National Action Week is held October 12-20 with activities focused on disorders including arthritis, back pain, osteoporosis, and the effects of childhood obesity on the musculoskeletal system. Events and projects organized worldwide are designed to raise awareness of prevention, disease management and treatments. In the United States, the U.S. Bone and Joint Decade represents the global initiative.

14 Oct 2010

$FDA warns of risk of atypical thigh bone fracture in patients taking bisphosphonates$

FDA warns of risk of atypical thigh bone fracture in patients taking bisphosphonates

The U.S. Food and Drug Administration today warned patients and health care providers about the possible risk of atypical thigh bone (femoral) fracture in patients who take bisphosphonates, a class of drugs used to prevent and treat osteoporosis. A labeling change and Medication Guide will reflect this risk. Bisphosphonates inhibit the loss of bone mass in people with osteoporosis.

14 Oct 2010

Ligand launches Viviant in Japan and Spain for postmenopausal osteoporosis

Ligand Pharmaceuticals Incorporated today announced that its partner Pfizer, Inc. launched Viviant® (Bazedoxifene) in Japan for the treatment of postmenopausal osteoporosis. Under the brand name Conbriza®, the drug is also marketed in Spain through a co-promotion with Almirall, an international pharmaceutical company based in Spain.

14 Oct 2010

Four British Columbia students awarded 2010 UCBeyond Scholarship

For four students from British Columbia, their stories of perseverance in pursuing their hopes and dreams despite their illnesses is why they have been awarded $5,000 CAN each as the 2010 recipients of the UCBeyond Scholarship.

13 Oct 2010

New 2010 clinical practice guidelines for diagnosis and management of osteoporosis in Canada released

Today, Osteoporosis Canada released its 2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada, published in the Canadian Medical Association Journal. The new guidelines represent a paradigm shift in the prevention and treatment of osteoporotic fractures, moving the focus from treating low bone mineral density (BMD) to better identifying fractures caused by weakened bones (fragility fractures).

12 Oct 2010

$Photographic exhibition reveals devastating impact of spinal osteoporotic fractures$

Photographic exhibition reveals devastating impact of spinal osteoporotic fractures

At a press conference held in Brussels today, the International Osteoporosis Foundation (IOF), the Belgian Bone Club and the European Parliament Osteoporosis Interest Group called on health care professionals and health policy officials in Europe to take action to prevent spinal fractures. The call to action was made at the launch of a unique photographic essay, 'snap! the breaking spine', leading up to World Osteoporosis Day on October 20, 2010.

12 Oct 2010

$Osteoporosis Canada issues new guidelines to prevent fragility fractures$

Osteoporosis Canada issues new guidelines to prevent fragility fractures

Comprehensive new guidelines from the Osteoporosis Canada aimed at preventing fragility fractures in women and men over the age of 50 are published in CMAJ.

12 Oct 2010

Tips to keep bones strong

October 20 is World Osteoporosis Day. Most people know that osteoporosis is a condition that affects many older women. Though osteoporosis isn't as common in men -- because most men have naturally larger and stronger bones -- they can get it, too.

11 Oct 2010

Best defense against osteoporosis begins in childhood

While osteoporosis most typically affects persons over age 50, the best defense against it begins in childhood.

11 Oct 2010

FDA approves Warner Chilcott's ACTONEL for postmenopausal osteoporosis

Warner Chilcott plc today announced that the United States Food and Drug Administration (FDA) has approved its next generation ACTONEL® (risedronate sodium) product for the treatment of postmenopausal osteoporosis in the United States. The product will be marketed as ATELVIA™ (risedronate sodium) delayed-release tablets.

11 Oct 2010

Raloxifene drug may be useful in treating kidney disease in women: Study

The osteoporosis drug raloxifene may be useful in treating kidney disease in women, suggests a new study led by Michal Melamed, M.D., M.H.S., assistant professor of medicine and epidemiology & population health at the Albert Einstein College of Medicine of Yeshiva University.

7 Oct 2010

Osteoporosis News and Research

Latest Osteoporosis News and Research

Study: Half of Canadians with osteoporosis have insufficient levels of vitamin D

Study indicates vitamin D deficiency may increase lung transplant rejection

IBD patients with Vitamin D deficiency at greater risk of osteoporosis, osteopenia

14 global studies on osteoporosis medications FORTEO and EVISTA to be presented at ASBMR 2010

Women with normal bone mineral density at age 67 don't need osteoporosis screening again for 10 years

Six-year data of reinforces efficacy and safety of Reclast injection in postmenopausal women with osteoporosis

Researchers identify genes that predict early menopause

Spinal fractures remain undiagnosed and untreated

Officials address several drug issues including medical risks, proper disposal of unused medicine

U.S. Bone and Joint Decade observes National Action Week

FDA warns of risk of atypical thigh bone fracture in patients taking bisphosphonates

Ligand launches Viviant in Japan and Spain for postmenopausal osteoporosis

Four British Columbia students awarded 2010 UCBeyond Scholarship

New 2010 clinical practice guidelines for diagnosis and management of osteoporosis in Canada released

Photographic exhibition reveals devastating impact of spinal osteoporotic fractures

Osteoporosis Canada issues new guidelines to prevent fragility fractures

Tips to keep bones strong

Best defense against osteoporosis begins in childhood

FDA approves Warner Chilcott's ACTONEL for postmenopausal osteoporosis

Raloxifene drug may be useful in treating kidney disease in women: Study

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Osteoporosis News and Research

Latest Osteoporosis News and Research

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Newsletters you may be interested in